Charles River Laboratories International (CRL) Competitors $187.90 +1.80 (+0.97%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends CRL vs. A, MTD, WAT, ILMN, TECH, BIO, BRKR, PACB, HBIO, and TMOShould you be buying Charles River Laboratories International stock or one of its competitors? The main competitors of Charles River Laboratories International include Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and Thermo Fisher Scientific (TMO). These companies are all part of the "life sciences tools & services" industry. Charles River Laboratories International vs. Agilent Technologies Mettler-Toledo International Waters Illumina Bio-Techne Bio-Rad Laboratories Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Charles River Laboratories International (NYSE:CRL) and Agilent Technologies (NYSE:A) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, dividends, risk, community ranking, profitability, analyst recommendations, media sentiment, earnings and institutional ownership. Is CRL or A more profitable? Agilent Technologies has a net margin of 21.75% compared to Charles River Laboratories International's net margin of 10.44%. Agilent Technologies' return on equity of 25.26% beat Charles River Laboratories International's return on equity.Company Net Margins Return on Equity Return on Assets Charles River Laboratories International10.44% 14.29% 6.53% Agilent Technologies 21.75%25.26%14.00% Does the MarketBeat Community favor CRL or A? Agilent Technologies received 369 more outperform votes than Charles River Laboratories International when rated by MarketBeat users. Likewise, 71.25% of users gave Agilent Technologies an outperform vote while only 60.32% of users gave Charles River Laboratories International an outperform vote. CompanyUnderperformOutperformCharles River Laboratories InternationalOutperform Votes49160.32% Underperform Votes32339.68% Agilent TechnologiesOutperform Votes86071.25% Underperform Votes34728.75% Which has better earnings & valuation, CRL or A? Agilent Technologies has higher revenue and earnings than Charles River Laboratories International. Charles River Laboratories International is trading at a lower price-to-earnings ratio than Agilent Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCharles River Laboratories International$4.13B2.33$474.62M$7.9923.52Agilent Technologies$6.83B5.41$1.24B$4.8226.67 Do insiders and institutionals hold more shares of CRL or A? 98.9% of Charles River Laboratories International shares are held by institutional investors. 1.3% of Charles River Laboratories International shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Do analysts recommend CRL or A? Charles River Laboratories International presently has a consensus target price of $214.38, indicating a potential upside of 14.10%. Agilent Technologies has a consensus target price of $144.36, indicating a potential upside of 12.28%. Given Charles River Laboratories International's higher possible upside, equities research analysts plainly believe Charles River Laboratories International is more favorable than Agilent Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Charles River Laboratories International 3 Sell rating(s) 10 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.93Agilent Technologies 1 Sell rating(s) 5 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.50 Does the media favor CRL or A? In the previous week, Agilent Technologies had 6 more articles in the media than Charles River Laboratories International. MarketBeat recorded 20 mentions for Agilent Technologies and 14 mentions for Charles River Laboratories International. Agilent Technologies' average media sentiment score of 1.17 beat Charles River Laboratories International's score of 0.98 indicating that Agilent Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Charles River Laboratories International 10 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Agilent Technologies 12 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, CRL or A? Charles River Laboratories International has a beta of 1.38, suggesting that its stock price is 38% more volatile than the S&P 500. Comparatively, Agilent Technologies has a beta of 1.07, suggesting that its stock price is 7% more volatile than the S&P 500. SummaryAgilent Technologies beats Charles River Laboratories International on 13 of the 18 factors compared between the two stocks. Ad WealthPressBreaking News: Tesla headed to $500…That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRL vs. The Competition Export to ExcelMetricCharles River Laboratories InternationalCommercial physical research IndustryMedical SectorNYSE ExchangeMarket Cap$9.61B$4.37B$5.05B$19.88BDividend YieldN/A1.63%5.17%3.54%P/E Ratio23.5256.30123.8942.92Price / Sales2.3359.581,181.4218.13Price / Cash11.1725.6933.6617.85Price / Book2.683.194.685.52Net Income$474.62M$139.66M$119.38M$985.93M7 Day Performance-9.02%-4.81%-2.46%-0.22%1 Month Performance-4.99%14.86%-4.07%0.12%1 Year Performance-1.38%30.64%29.77%23.70% Charles River Laboratories International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRLCharles River Laboratories International4.8024 of 5 stars$187.90+1.0%$214.38+14.1%-1.4%$9.61B$4.13B23.5221,800Analyst DowngradeAAgilent Technologies4.3924 of 5 stars$130.00+1.1%$144.36+11.0%+12.8%$37.35B$6.83B26.6718,100Upcoming EarningsNews CoveragePositive NewsMTDMettler-Toledo International4.1104 of 5 stars$1,166.90+0.5%$1,338.75+14.7%+11.1%$24.62B$3.79B31.4617,300Positive NewsWATWaters4.1245 of 5 stars$357.69+3.8%$365.85+2.3%+37.0%$21.24B$2.96B34.137,900ILMNIllumina4.5866 of 5 stars$131.94+0.2%$164.00+24.3%+34.9%$20.93B$4.50B0.009,300Positive NewsTECHBio-Techne4.8569 of 5 stars$68.72+3.5%$81.78+19.0%+8.1%$10.92B$1.16B73.113,100BIOBio-Rad Laboratories4.7211 of 5 stars$323.69+0.9%$391.80+21.0%+6.3%$9.06B$2.67B0.008,030Positive NewsBRKRBruker4.9986 of 5 stars$53.79+0.8%$79.36+47.5%-12.9%$8.15B$2.96B25.669,707Dividend AnnouncementInsider TradeGap UpPACBPacific Biosciences of California1.5162 of 5 stars$1.74+1.2%$3.63+108.3%-80.0%$476.52M$200.52M0.00730Analyst RevisionHBIOHarvard Bioscience1.5634 of 5 stars$2.16+5.4%N/A-48.8%$94.22M$112.25M-6.55490Positive NewsTMOThermo Fisher Scientific4.9906 of 5 stars$512.86+0.7%$649.33+26.6%+9.3%$196.17B$42.86B32.15122,000Buyback AnnouncementPositive News Related Companies and Tools Related Companies Agilent Technologies Alternatives Mettler-Toledo International Alternatives Waters Alternatives Illumina Alternatives Bio-Techne Alternatives Bio-Rad Laboratories Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Thermo Fisher Scientific Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:CRL) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Charles River Laboratories International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.